The Mills administration has submitted a plan to the federal government to distribute a vaccine for COVID-19.
Pfizer's vaccine is one of the frontrunners among those being developed around the world.
Bourla's emphasis on having data in October "is what got many of us concerned, whether it was inadvertently playing into the political pressure or just because the incentives were aligned", Topol said.
Pfizer Inc said on Friday it could file for USA authorization of the COVID-19 vaccine it is developing with German partner BioNTech in late November, suggesting it is possible a vaccine could be available in the United States this year.
Without further data on how effective the vaccine is and how long immunity from it may last, it's also hard to know what impact any of the shots now in phase III trials will have on controlling the pandemic.
The firm is conducting final phase-three trials of a vaccine it is co-developing with German partner BioNTech.
"I've said before, we are operating at the speed of science".Читайте также: Musk sees 'fighting chance' for Starship mission to Mars in 2024
This is the first time any "leading Western vaccine developer provided such a specific timeline", according to the Wall Street Journal.
Then, in late September, more than 60 researchers and bioethicists urged Pfizer to wait until late November at earliest to file its vaccine for FDA review, arguing a submission before accruing at least two months of safety data would "severely erode public trust and set back efforts to achieve widespread vaccination". In October, "the truth will be revealed", was what he told The Washington Post.
AstraZeneca and J&J each have been forced to hit pause on their trials to investigate an unexplained illness in their respective trials. The company pointed out that illnesses, even severe cases, "are an expected part of any clinical study, especially large studies".
On Tuesday, pharmaceutical company Eli Lilly said it paused a government-sponsored antibody treatment trial because of a "potential safety concern". Even if that were so, a pre-election vaccine would mean the Food and Drug Administration would have to give an nearly immediate thumbs-up. But the day a vaccine is approved will not be the day COVID-19 comes to an end. "Distribution will begin within 24 hours", President Trump said. A vaccine was the only route to herd immunity, he said.
The CDC anticipates that up to 700 million doses of vaccine will be available in April of 2021, enough to vaccinate all Americans because most vaccines in development require two doses per person.При любом использовании материалов сайта и дочерних проектов, гиперссылка на обязательна.
«» 2007 - 2020 Copyright.
Автоматизированное извлечение информации сайта запрещено.
Код для вставки в блог